This topic contains a solution. Click here to go to the answer

Author Question: Why are patients with plasma cell myeloma susceptible to infection? a. Decreased lymphocytes b. ... (Read 100 times)

tth

  • Hero Member
  • *****
  • Posts: 579
Why are patients with plasma cell myeloma susceptible to infection?
 
  a. Decreased lymphocytes
  b. Neutropenia
  c. Suppressed normal immunoglobulin levels
  d. Both b and c

Question 2

Why is Burkitt lymphoma such an aggressive malignancy?
 
  a. Cells readily metastasize to bone marrow.
  b. Cells have a high proliferative rate.
  c. Cells fail to mature to functional immunophenotype.
  d. Cells destroy red cells.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagnavarro

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D
As plasma cells multiply in the bone marrow, normal hematopoiesis, including granulopoiesis, is suppressed. This leads to neutropenia. In addition, normal immunoglobulin (antibodies) is suppressed. Together these contribute to the increased susceptibility to infection seen in these patients.

Answer to Question 2

ANS: B
Burkitt lymphoma cells have a high proliferative rate, with a very short doubling time; almost all the malignant cells are in active phases of the cell cycle at any one time.





 

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library